- Home
- Gastroenterology
- Empagliflozin in CKD: Slowing Disease Progression Beyond Glycaemic Control

1mo3 min read
Medical Article
Introduction / Case Summary: A 62-year-old man with type 2 diabetes mellitus (T2DM), hypertension, and stage 3 chronic kidney disease (CKD) showed progressive decline in estimated glomerular filtration rate (eGFR) and persistent albuminuria despite renin–angiotensin system [RAS] blockade. Baseline values: eGFR 42 mL/min/1.73 m², urinary albumin-to-

Empagliflozin in CKD: Slowing Disease Progression Beyond Glycaemic Control
270 Reached
Similar Content

Pregnant Woman with HIV-1 Infection
747 Reached1 Likes

Male with Jaw Pain and Abdominal Bloating
790 Reached24 Comments26 Likes

Study evaluating Effectiveness of Bacillus clausii for Treatment of Rotavirus Infection
1303 Reached4 Comments6 Likes

SECCA for Managing Anal Incontinence
203 Reached2 Comments2 Likes

Single-incision Laparoscopy for Gastrostomy
408 Reached2 Comments1 Likes